{"derived":{"adj":{"INE159A01":[{"cum_after":1.0,"cum_from":0.5,"event_ids":["INE159A01:2018-09-11:bonus:0"],"ex":"2018-09-11","factor":0.5,"types":["bonus"]}]},"dividends":{"bridged":true,"first_fy":"FY2001-02","fy":{"FY2001-02":{"adj":5.25,"dps":10.5,"n":2,"partial":false},"FY2005-06":{"adj":14.0,"dps":28.0,"n":2,"partial":false},"FY2006-07":{"adj":15.5,"dps":31.0,"n":2,"partial":false},"FY2008-09":{"adj":38.0,"dps":76.0,"n":4,"partial":false},"FY2009-10":{"adj":15.0,"dps":30.0,"n":1,"partial":false},"FY2010-11":{"adj":20.0,"dps":40.0,"n":1,"partial":false},"FY2011-12":{"adj":22.5,"dps":45.0,"n":1,"partial":false},"FY2013-14":{"adj":25.0,"dps":50.0,"n":1,"partial":false},"FY2014-15":{"adj":25.0,"dps":50.0,"n":1,"partial":false},"FY2015-16":{"adj":31.25,"dps":62.5,"n":1,"partial":false},"FY2016-17":{"adj":25.0,"dps":50.0,"n":1,"paid_cr":423.52,"partial":false},"FY2017-18":{"adj":15.0,"dps":30.0,"n":1,"paid_cr":254.11,"partial":false},"FY2018-19":{"adj":17.5,"dps":35.0,"n":1,"paid_cr":296.46,"partial":false},"FY2019-20":{"adj":20.0,"dps":20.0,"n":1,"paid_cr":338.81,"partial":false},"FY2020-21":{"adj":40.0,"dps":40.0,"n":2,"paid_cr":677.62,"partial":false},"FY2021-22":{"adj":30.0,"dps":30.0,"n":1,"paid_cr":508.22,"partial":false},"FY2022-23":{"adj":90.0,"dps":90.0,"n":2,"paid_cr":1524.66,"partial":false},"FY2023-24":{"adj":32.0,"dps":32.0,"n":1,"paid_cr":542.1,"partial":false},"FY2024-25":{"adj":44.0,"dps":44.0,"n":2,"paid_cr":745.39,"partial":false},"FY2025-26":{"adj":42.0,"dps":42.0,"n":1,"paid_cr":711.51,"partial":false},"FY2026-27":{"adj":57.0,"dps":57.0,"n":1,"paid_cr":965.61,"partial":false}},"fy_dps":42.0,"fy_last":"FY2025-26","fy_paid_cr":711.51,"held":0,"last_ex":"2026-05-29","open":true,"paid_ttm_cr":965.61,"payouts":30,"raised":0,"shares_asof":"2026-09-30","shares_out":169409448,"since":"FY2001-02","streak":26,"streak_ended":null,"ttm_dps":57.0,"ttm_n":1,"ttm_partial":false,"years_on_record":21,"yield_fy":1.58,"yield_ttm":2.15},"dividends_by_fy":{"INE159A01":{"FY2001-02":{"distribution":0.0,"final":0.0,"interim":0.0,"n":2,"pct_only":0,"special":0.0,"total":10.5,"unspecified":10.5},"FY2005-06":{"distribution":0.0,"final":14.0,"interim":0.0,"n":2,"pct_only":0,"special":14.0,"total":28.0,"unspecified":0.0},"FY2006-07":{"distribution":0.0,"final":17.0,"interim":0.0,"n":2,"pct_only":0,"special":14.0,"total":31.0,"unspecified":0.0},"FY2008-09":{"distribution":0.0,"final":40.0,"interim":0.0,"n":4,"pct_only":0,"special":36.0,"total":76.0,"unspecified":0.0},"FY2009-10":{"distribution":0.0,"final":0.0,"interim":0.0,"n":1,"pct_only":0,"special":0.0,"total":30.0,"unspecified":30.0},"FY2010-11":{"distribution":0.0,"final":0.0,"interim":0.0,"n":1,"pct_only":0,"special":0.0,"total":40.0,"unspecified":40.0},"FY2011-12":{"distribution":0.0,"final":0.0,"interim":0.0,"n":1,"pct_only":0,"special":0.0,"total":45.0,"unspecified":45.0},"FY2013-14":{"distribution":0.0,"final":50.0,"interim":0.0,"n":1,"pct_only":0,"special":0.0,"total":50.0,"unspecified":0.0},"FY2014-15":{"distribution":0.0,"final":50.0,"interim":0.0,"n":1,"pct_only":0,"special":0.0,"total":50.0,"unspecified":0.0},"FY2015-16":{"distribution":0.0,"final":62.5,"interim":0.0,"n":1,"pct_only":0,"special":0.0,"total":62.5,"unspecified":0.0},"FY2016-17":{"distribution":0.0,"final":50.0,"interim":0.0,"n":1,"pct_only":0,"special":0.0,"total":50.0,"unspecified":0.0},"FY2017-18":{"distribution":0.0,"final":30.0,"interim":0.0,"n":1,"pct_only":0,"special":0.0,"total":30.0,"unspecified":0.0},"FY2018-19":{"distribution":0.0,"final":35.0,"interim":0.0,"n":1,"pct_only":0,"special":0.0,"total":35.0,"unspecified":0.0},"FY2019-20":{"distribution":0.0,"final":20.0,"interim":0.0,"n":1,"pct_only":0,"special":0.0,"total":20.0,"unspecified":0.0},"FY2020-21":{"distribution":0.0,"final":20.0,"interim":0.0,"n":2,"pct_only":0,"special":20.0,"total":40.0,"unspecified":0.0},"FY2021-22":{"distribution":0.0,"final":30.0,"interim":0.0,"n":1,"pct_only":0,"special":0.0,"total":30.0,"unspecified":0.0},"FY2022-23":{"distribution":0.0,"final":30.0,"interim":0.0,"n":2,"pct_only":0,"special":60.0,"total":90.0,"unspecified":0.0},"FY2023-24":{"distribution":0.0,"final":32.0,"interim":0.0,"n":1,"pct_only":0,"special":0.0,"total":32.0,"unspecified":0.0},"FY2024-25":{"distribution":0.0,"final":32.0,"interim":12.0,"n":2,"pct_only":0,"special":0.0,"total":44.0,"unspecified":0.0},"FY2025-26":{"distribution":0.0,"final":42.0,"interim":0.0,"n":1,"pct_only":0,"special":0.0,"total":42.0,"unspecified":0.0},"FY2026-27":{"distribution":0.0,"final":57.0,"interim":0.0,"n":1,"pct_only":0,"special":0.0,"total":57.0,"unspecified":0.0}}}},"events":[{"announce":null,"bc_from":"2001-05-18","bc_to":"2001-06-04","bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"Rs 5 per share","event_id":"INE159A01:2001-05-02:dividend:0","ex":"2001-05-02","ex_move":{"move":2.85,"on":["2001-05-02",380.1],"pre":["2001-04-30",369.55]},"exchanges":["BSE"],"field_provenance":{"div_amount":"bse_dd"},"fields":{"div_amount":5.0},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":"2001-05-02","nd_to":"2001-05-16","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Dividend - Rs. - 5.0000","scrip":"500660","series":null,"src":"bse_dd","symbol":null}],"record":null,"series":null,"sources":["bse_dd"],"subtype":"unspecified","symbol":null,"type":"dividend"},{"announce":null,"bc_from":"2002-04-12","bc_to":"2002-04-26","bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"Rs 5.5 per share","event_id":"INE159A01:2002-03-27:dividend:0","ex":"2002-03-27","ex_move":{"move":-0.75,"on":["2002-03-27",337.65],"pre":["2002-03-26",340.2]},"exchanges":["BSE"],"field_provenance":{"div_amount":"bse_dd"},"fields":{"div_amount":5.5},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":"2002-03-27","nd_to":"2002-04-09","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Dividend - Rs. - 5.5000","scrip":"500660","series":null,"src":"bse_dd","symbol":null}],"record":null,"series":null,"sources":["bse_dd"],"subtype":"unspecified","symbol":null,"type":"dividend"},{"announce":null,"bc_from":"2006-03-28","bc_to":"2006-04-12","bse_scrip":null,"class":"equity","confidence":1.0,"detail":"Rs 14 per share","event_id":"INE159A01:2006-03-24:dividend:0","ex":"2006-03-24","ex_move":{"move":-0.37,"on":["2006-03-24",1347.35],"pre":["2006-03-23",1352.35]},"exchanges":["NSE"],"field_provenance":{"div_amount":"nse_api"},"fields":{"div_amount":14.0},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":null,"nd_to":null,"payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Fin Div-Rs14+Spl Div-Rs14","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"}],"record":null,"series":"EQ","sources":["nse_api"],"subtype":"final","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":"2006-03-28","bc_to":"2006-04-12","bse_scrip":null,"class":"equity","confidence":1.0,"detail":"Rs 14 per share","event_id":"INE159A01:2006-03-24:dividend:1","ex":"2006-03-24","ex_move":{"move":-0.37,"on":["2006-03-24",1347.35],"pre":["2006-03-23",1352.35]},"exchanges":["NSE"],"field_provenance":{"div_amount":"nse_api"},"fields":{"div_amount":14.0},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":null,"nd_to":null,"payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Fin Div-Rs14+Spl Div-Rs14","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"}],"record":null,"series":"EQ","sources":["nse_api"],"subtype":"special","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":"2007-03-16","bc_to":"2007-03-30","bse_scrip":null,"class":"equity","confidence":0.9,"detail":"Rs 17 per share","event_id":"INE159A01:2007-03-14:dividend:0","ex":"2007-03-14","ex_move":{"move":-0.88,"on":["2007-03-14",1169.85],"pre":["2007-03-13",1180.25]},"exchanges":["NSE"],"field_provenance":{"div_amount":"nse_api","div_pct_fv":"nse_api","fv_used":"nse_api"},"fields":{"div_amount":17.0,"div_pct_fv":170.0,"fv_used":10.0},"flags":["fv_assumed_current"],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":null,"nd_to":null,"payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Div Fin-170% + Spl-140%  Purpose Revised","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"}],"record":null,"series":"EQ","sources":["nse_api"],"subtype":"final","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":"2007-03-16","bc_to":"2007-03-30","bse_scrip":null,"class":"equity","confidence":0.9,"detail":"Rs 14 per share","event_id":"INE159A01:2007-03-14:dividend:1","ex":"2007-03-14","ex_move":{"move":-0.88,"on":["2007-03-14",1169.85],"pre":["2007-03-13",1180.25]},"exchanges":["NSE"],"field_provenance":{"div_amount":"nse_api","div_pct_fv":"nse_api","fv_used":"nse_api"},"fields":{"div_amount":14.0,"div_pct_fv":140.0,"fv_used":10.0},"flags":["fv_assumed_current"],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":null,"nd_to":null,"payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Div Fin-170% + Spl-140%  Purpose Revised","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"}],"record":null,"series":"EQ","sources":["nse_api"],"subtype":"special","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":"2008-04-04","bc_to":"2008-04-21","bse_scrip":null,"class":"equity","confidence":1.0,"detail":"Rs 18 per share","event_id":"INE159A01:2008-04-02:dividend:0","ex":"2008-04-02","ex_move":{"move":-2.28,"on":["2008-04-02",1026.4],"pre":["2008-04-01",1050.4]},"exchanges":["BSE","NSE"],"field_provenance":{"div_amount":"nse_api"},"fields":{"div_amount":18.0},"flags":["combined_total_absorbed"],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":null,"nd_to":null,"payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Div Fin-Rs18+Spl-18 Pr Sh","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"combined_total":true,"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Dividend - Rs. - 36.0000","scrip":"500660","series":null,"src":"bse_dd","symbol":null}],"record":null,"series":"EQ","sources":["nse_api","bse_dd"],"subtype":"final","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":"2008-04-04","bc_to":"2008-04-21","bse_scrip":null,"class":"equity","confidence":1.0,"detail":"Rs 18 per share","event_id":"INE159A01:2008-04-02:dividend:1","ex":"2008-04-02","ex_move":{"move":-2.28,"on":["2008-04-02",1026.4],"pre":["2008-04-01",1050.4]},"exchanges":["BSE","NSE"],"field_provenance":{"div_amount":"nse_api"},"fields":{"div_amount":18.0},"flags":["combined_total_absorbed"],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":null,"nd_to":null,"payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Div Fin-Rs18+Spl-18 Pr Sh","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"combined_total":true,"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Dividend - Rs. - 36.0000","scrip":"500660","series":null,"src":"bse_dd","symbol":null}],"record":null,"series":"EQ","sources":["nse_api","bse_dd"],"subtype":"special","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":"2009-03-20","bc_to":"2009-04-02","bse_scrip":null,"class":"equity","confidence":1.0,"detail":"Rs 22 per share","event_id":"INE159A01:2009-03-18:dividend:0","ex":"2009-03-18","ex_move":{"move":-5.29,"on":["2009-03-18",1093.8],"pre":["2009-03-17",1154.9]},"exchanges":["BSE","NSE"],"field_provenance":{"div_amount":"nse_api"},"fields":{"div_amount":22.0},"flags":["combined_total_absorbed"],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":null,"nd_to":null,"payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Div Fin-Rs.22 + Spl-Rs.18","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"combined_total":true,"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Dividend - Rs. - 40.0000","scrip":"500660","series":null,"src":"bse_dd","symbol":null}],"record":null,"series":"EQ","sources":["nse_api","bse_dd"],"subtype":"final","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":"2009-03-20","bc_to":"2009-04-02","bse_scrip":null,"class":"equity","confidence":1.0,"detail":"Rs 18 per share","event_id":"INE159A01:2009-03-18:dividend:1","ex":"2009-03-18","ex_move":{"move":-5.29,"on":["2009-03-18",1093.8],"pre":["2009-03-17",1154.9]},"exchanges":["BSE","NSE"],"field_provenance":{"div_amount":"nse_api"},"fields":{"div_amount":18.0},"flags":["combined_total_absorbed"],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":null,"nd_to":null,"payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Div Fin-Rs.22 + Spl-Rs.18","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"combined_total":true,"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Dividend - Rs. - 40.0000","scrip":"500660","series":null,"src":"bse_dd","symbol":null}],"record":null,"series":"EQ","sources":["nse_api","bse_dd"],"subtype":"special","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":"2010-03-12","bc_to":"2010-03-25","bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"Rs 30 per share","event_id":"INE159A01:2010-03-10:dividend:0","ex":"2010-03-10","ex_move":{"move":0.95,"on":["2010-03-10",1767.65],"pre":["2010-03-09",1750.95]},"exchanges":["BSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc"},"fields":{"div_amount":30.0},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":"2010-03-05","nd_to":"2010-03-11","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2010-02-15","last_seen":"2010-03-23","purpose":"DIVIDEND-RS.30/- PR SHARE","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2010-02-15","last_seen":"2010-03-23","purpose":"DIVIDEND-RS.30/- PR SHARE","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Dividend-Rs.30/- Pr Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Dividend - Rs. - 30.0000","scrip":"500660","series":null,"src":"bse_dd","symbol":null}],"record":null,"series":"BE","sources":["nse_pr_bc","nse_api","bse_dd"],"subtype":"unspecified","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":"2011-03-16","bc_to":"2011-03-29","bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"Rs 40 per share","event_id":"INE159A01:2011-03-14:dividend:0","ex":"2011-03-14","ex_move":{"move":-2.28,"on":["2011-03-14",2122.4],"pre":["2011-03-11",2171.95]},"exchanges":["BSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc"},"fields":{"div_amount":40.0},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":"2011-03-09","nd_to":"2011-03-15","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2011-02-15","last_seen":"2011-03-28","purpose":"DIVIDEND-RS.40/- PR SHARE","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2011-02-15","last_seen":"2011-03-28","purpose":"DIVIDEND-RS.40/- PR SHARE","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Dividend-Rs.40/- Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Dividend - Rs. - 40.0000","scrip":"500660","series":null,"src":"bse_dd","symbol":null}],"record":null,"series":"BE","sources":["nse_pr_bc","nse_api","bse_dd"],"subtype":"unspecified","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":"2012-04-02","bc_to":"2012-04-10","bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"Rs 45 per share","event_id":"INE159A01:2012-03-29:dividend:0","ex":"2012-03-29","ex_move":{"move":-1.46,"on":["2012-03-29",2223.75],"pre":["2012-03-28",2256.8]},"exchanges":["BSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc"},"fields":{"div_amount":45.0},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":"2012-03-26","nd_to":"2012-03-29","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2012-03-19","last_seen":"2012-04-09","purpose":"DIVIDEND-RS.45/- PR SHARE","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2012-03-19","last_seen":"2012-04-09","purpose":"DIVIDEND-RS.45/- PR SHARE","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Dividend Rs.45/- Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Dividend - Rs. - 45.0000","scrip":"500660","series":null,"src":"bse_dd","symbol":null}],"record":null,"series":"BE","sources":["nse_pr_bc","nse_api","bse_dd"],"subtype":"unspecified","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":"2013-04-08","bc_to":"2013-04-16","bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"Rs 50 per share","event_id":"INE159A01:2013-04-04:dividend:0","ex":"2013-04-04","ex_move":{"move":-2.98,"on":["2013-04-04",2200.95],"pre":["2013-04-03",2268.55]},"exchanges":["BSE","MSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc"},"fields":{"div_amount":50.0},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":"2013-03-28","nd_to":"2013-04-05","payment":"2013-04-17","price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2013-03-05","last_seen":"2013-04-15","purpose":"DIVIDEND RS. 50 PER SHARE","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2013-03-05","last_seen":"2013-04-15","purpose":"DIVIDEND RS. 50 PER SHARE","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Dividend Rs. 50 Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Dividend - Rs. - 50.0000","scrip":"500660","series":null,"src":"bse_dd","symbol":null},{"ex_from_record":false,"first_seen":"2026-10-05","last_seen":"2026-10-06","mse_symbol":"GLAXO","purpose":"Final Dividend - Rs.50/- per share","scrip":null,"series":null,"src":"mse_ca","symbol":null}],"record":null,"series":"BE","sources":["nse_pr_bc","nse_api","bse_dd","mse_ca"],"subtype":"final","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":"2014-04-07","bc_to":"2014-04-17","bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"Rs 50 per share","event_id":"INE159A01:2014-04-03:dividend:0","ex":"2014-04-03","ex_move":{"move":-0.73,"on":["2014-04-03",2571.1],"pre":["2014-04-02",2589.95]},"exchanges":["BSE","MSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc"},"fields":{"div_amount":50.0},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":"2014-03-27","nd_to":"2014-04-04","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2014-03-27","last_seen":"2014-04-16","purpose":"DIVIDEND RS.50/- PER SH","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2014-03-27","last_seen":"2014-04-16","purpose":"DIVIDEND RS.50/- PER SH","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Final Dividend Rs.50/- Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Dividend - Rs. - 50.0000","scrip":"500660","series":null,"src":"bse_dd","symbol":null},{"ex_from_record":false,"first_seen":"2026-10-05","last_seen":"2026-10-06","mse_symbol":"GLAXO","purpose":"Final Dividend Rs. 50/- per share","scrip":null,"series":null,"src":"mse_ca","symbol":null}],"record":null,"series":"BE","sources":["nse_pr_bc","nse_api","bse_dd","mse_ca"],"subtype":"final","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":"2015-07-25","bc_to":"2015-07-31","bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"Rs 62.5 per share","event_id":"INE159A01:2015-07-23:dividend:0","ex":"2015-07-23","ex_move":{"move":-0.99,"on":["2015-07-23",3403.0],"pre":["2015-07-22",3436.9]},"exchanges":["BSE","MSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc"},"fields":{"div_amount":62.5},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":"2015-07-20","nd_to":"2015-07-23","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2015-06-03","last_seen":"2015-07-30","purpose":"AGM/DIV-RS 62.50 PERSHARE","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2015-06-03","last_seen":"2015-07-30","purpose":"AGM/DIV-RS 62.50 PERSHARE","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Annual General Meeting/Dividend - Rs 62..50/- Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Dividend - Rs. - 62.5000","scrip":"500660","series":null,"src":"bse_dd","symbol":null},{"ex_from_record":false,"first_seen":"2026-10-05","last_seen":"2026-10-06","mse_symbol":"GLAXO","purpose":"AGM/Final Dividend Rs. 62.50/- per share","scrip":null,"series":null,"src":"mse_ca","symbol":null}],"record":null,"series":"BE","sources":["nse_pr_bc","nse_api","bse_dd","mse_ca"],"subtype":"final","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":"2015-07-25","bc_to":"2015-07-31","bse_scrip":null,"class":"equity","confidence":1.0,"detail":"","event_id":"INE159A01:2015-07-23:meeting:0","ex":"2015-07-23","exchanges":["MSE","NSE"],"field_provenance":{},"fields":{},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":null,"nd_to":null,"payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2015-06-03","last_seen":"2015-07-30","purpose":"AGM/DIV-RS 62.50 PERSHARE","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2015-06-03","last_seen":"2015-07-30","purpose":"AGM/DIV-RS 62.50 PERSHARE","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Annual General Meeting/Dividend - Rs 62..50/- Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-10-05","last_seen":"2026-10-06","mse_symbol":"GLAXO","purpose":"AGM/Final Dividend Rs. 62.50/- per share","scrip":null,"series":null,"src":"mse_ca","symbol":null}],"record":null,"series":"BE","sources":["nse_pr_bc","nse_api","mse_ca"],"subtype":"agm","symbol":"GLAXO","type":"meeting"},{"announce":null,"bc_from":"2016-07-19","bc_to":"2016-07-28","bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"Rs 50 per share","event_id":"INE159A01:2016-07-15:dividend:0","ex":"2016-07-15","ex_move":{"move":-1.79,"on":["2016-07-15",3458.95],"pre":["2016-07-14",3522.05]},"exchanges":["BSE","MSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc"},"fields":{"div_amount":50.0,"payout_cr":423.52},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":"2016-07-12","nd_to":"2016-07-18","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2016-06-03","last_seen":"2016-07-27","purpose":"DIV RS 50/- PER SHARE","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2016-06-03","last_seen":"2016-07-27","purpose":"DIV RS 50/- PER SHARE","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Dividend Rs 50/- Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Dividend - Rs. - 50.0000","scrip":"500660","series":null,"src":"bse_dd","symbol":null},{"ex_from_record":false,"first_seen":"2026-10-05","last_seen":"2026-10-06","mse_symbol":"GLAXO","purpose":"AGM/Final Dividend Rs. 50/- per share","scrip":null,"series":null,"src":"mse_ca","symbol":null}],"record":null,"series":"BE","sources":["nse_pr_bc","nse_api","bse_dd","mse_ca"],"subtype":"final","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":"2017-07-18","bc_to":"2017-07-25","bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"Rs 30 per share","event_id":"INE159A01:2017-07-14:dividend:0","ex":"2017-07-14","ex_move":{"move":-1.01,"on":["2017-07-14",2560.85],"pre":["2017-07-13",2587.05]},"exchanges":["BSE","MSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc"},"fields":{"div_amount":30.0,"payout_cr":254.11},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":"2017-07-11","nd_to":"2017-07-17","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2017-05-31","last_seen":"2017-07-24","purpose":"DIV-RS 30 PER SHARE","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2017-05-31","last_seen":"2017-07-24","purpose":"DIV-RS 30 PER SHARE","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Dividend - Rs 30/- Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Dividend - Rs. - 30.0000","scrip":"500660","series":null,"src":"bse_dd","symbol":null},{"ex_from_record":false,"first_seen":"2026-10-05","last_seen":"2026-10-06","mse_symbol":"GLAXO","purpose":"AGM/Final Dividend Rs. 30/- per share","scrip":null,"series":null,"src":"mse_ca","symbol":null}],"record":null,"series":"BE","sources":["nse_pr_bc","nse_api","bse_dd","mse_ca"],"subtype":"final","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":"2018-07-17","bc_to":"2018-07-24","bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"Rs 35 per share","event_id":"INE159A01:2018-07-13:dividend:0","ex":"2018-07-13","ex_move":{"move":0.05,"on":["2018-07-13",2847.05],"pre":["2018-07-12",2845.5]},"exchanges":["BSE","MSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc"},"fields":{"div_amount":35.0,"payout_cr":296.46},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":"2018-07-10","nd_to":"2018-07-16","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2018-06-06","last_seen":"2018-07-23","purpose":"DIV-RS 35 PER SHARE","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2018-06-06","last_seen":"2018-07-23","purpose":"DIV-RS 35 PER SHARE","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Dividend- Rs 35 Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Dividend - Rs. - 35.0000","scrip":"500660","series":null,"src":"bse_dd","symbol":null},{"ex_from_record":false,"first_seen":"2026-10-05","last_seen":"2026-10-06","mse_symbol":"GLAXO","purpose":"AGM/Final Dividend Rs. 35/- per share","scrip":null,"series":null,"src":"mse_ca","symbol":null}],"record":null,"series":"BE","sources":["nse_pr_bc","nse_api","bse_dd","mse_ca"],"subtype":"final","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":null,"bc_to":null,"bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"1:1","event_id":"INE159A01:2018-09-11:bonus:0","ex":"2018-09-11","ex_move":{"factor":0.5,"move":-2.59,"on":["2018-09-11",1748.55],"pre":["2018-09-10",3590.1]},"exchanges":["BSE","MSE","NSE"],"field_provenance":{"adj_factor":"nse_pr_bc","bonus_den":"nse_pr_bc","bonus_num":"nse_pr_bc"},"fields":{"adj_factor":0.5,"bonus_den":1,"bonus_num":1},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":"2018-09-06","nd_to":"2018-09-11","payment":null,"price_adjust":true,"qtychange":true,"raw":[{"ex_from_record":false,"first_seen":"2018-08-28","last_seen":"2018-09-12","purpose":"BONUS 1:1","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2018-08-28","last_seen":"2018-09-12","purpose":"BONUS 1:1","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Bonus 1:1","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Bonus issue 1:1","scrip":"500660","series":null,"src":"bse_dd","symbol":null},{"ex_from_record":false,"first_seen":"2026-10-05","last_seen":"2026-10-06","mse_symbol":"GLAXO","purpose":"Bonus 1 : 1","scrip":null,"series":null,"src":"mse_ca","symbol":null}],"record":"2018-09-13","series":"BE","sources":["nse_pr_bc","nse_api","bse_dd","mse_ca"],"subtype":null,"symbol":"GLAXO","type":"bonus"},{"announce":null,"bc_from":"2019-07-15","bc_to":"2019-07-22","bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"Rs 20 per share","event_id":"INE159A01:2019-07-11:dividend:0","ex":"2019-07-11","ex_move":{"move":-2.21,"on":["2019-07-11",1140.05],"pre":["2019-07-10",1165.8]},"exchanges":["BSE","MSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc","div_pct_fv":"bse_corpact","fv_used":"bse_corpact"},"fields":{"div_amount":20.0,"div_pct_fv":200.0,"fv_used":10.0,"payout_cr":338.81},"flags":["fv_from_counterpart"],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":"2019-07-08","nd_to":"2019-07-12","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2019-06-03","last_seen":"2019-07-19","purpose":"AGM/DIV-RS 20 PER SH","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2019-06-03","last_seen":"2019-07-19","purpose":"AGM/DIV-RS 20 PER SH","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Annual General Meeting/Dividend Rs 20 Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Dividend - Rs. - 20.0000","scrip":"500660","series":null,"src":"bse_dd","symbol":null},{"ex_from_record":false,"first_seen":"2026-09-15","last_seen":"2026-11-11","purpose":"AGM,DP-200%","scrip":"500660","series":null,"src":"bse_corpact","symbol":null},{"ex_from_record":false,"first_seen":"2026-09-11","last_seen":"2026-11-12","purpose":"AGM,DP-200%","scrip":"500660","series":null,"src":"bse_corpact","symbol":null},{"ex_from_record":false,"first_seen":"2026-10-05","last_seen":"2026-10-06","mse_symbol":"GLAXO","purpose":"AGM/Final Dividend Rs. 20/- per share","scrip":null,"series":null,"src":"mse_ca","symbol":null}],"record":null,"series":"BE","sources":["nse_pr_bc","nse_api","bse_dd","bse_corpact","mse_ca"],"subtype":"final","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":"2019-07-15","bc_to":"2019-07-22","bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"","event_id":"INE159A01:2019-07-11:meeting:0","ex":"2019-07-11","exchanges":["BSE","MSE","NSE"],"field_provenance":{},"fields":{},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":null,"nd_to":null,"payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2019-06-03","last_seen":"2019-07-19","purpose":"AGM/DIV-RS 20 PER SH","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2019-06-03","last_seen":"2019-07-19","purpose":"AGM/DIV-RS 20 PER SH","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Annual General Meeting/Dividend Rs 20 Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-09-15","last_seen":"2026-11-11","purpose":"AGM,DP-200%","scrip":"500660","series":null,"src":"bse_corpact","symbol":null},{"ex_from_record":false,"first_seen":"2026-09-11","last_seen":"2026-11-12","purpose":"AGM,DP-200%","scrip":"500660","series":null,"src":"bse_corpact","symbol":null},{"ex_from_record":false,"first_seen":"2026-10-05","last_seen":"2026-10-06","mse_symbol":"GLAXO","purpose":"AGM/Final Dividend Rs. 20/- per share","scrip":null,"series":null,"src":"mse_ca","symbol":null}],"record":null,"series":"BE","sources":["nse_pr_bc","nse_api","bse_corpact","mse_ca"],"subtype":"agm","symbol":"GLAXO","type":"meeting"},{"announce":null,"bc_from":null,"bc_to":null,"bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"Rs 20 per share","event_id":"INE159A01:2020-07-17:dividend:0","ex":"2020-07-17","ex_move":{"move":-1.87,"on":["2020-07-17",1519.2],"pre":["2020-07-16",1548.1]},"exchanges":["BSE","MSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc"},"fields":{"div_amount":20.0,"payout_cr":338.81},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":"2020-07-13","nd_to":"2020-07-17","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2020-06-17","last_seen":"2020-07-17","purpose":"DIV-RS 20 SPLDIV-RS 20","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2020-06-17","last_seen":"2020-07-17","purpose":"DIV-RS 20 SPLDIV-RS 20","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Dividend - Rs 20 And Special Dividend - Rs 20 Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Final Dividend - Rs. - 20.0000","scrip":"500660","series":null,"src":"bse_dd","symbol":null},{"ex_from_record":false,"first_seen":"2026-10-05","last_seen":"2026-10-06","mse_symbol":"GLAXO","purpose":"AGM/Final Div Rs. 20/- & Special Div Rs. 20/-","scrip":null,"series":null,"src":"mse_ca","symbol":null}],"record":"2020-07-20","series":"BE","sources":["nse_pr_bc","nse_api","bse_dd","mse_ca"],"subtype":"final","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":null,"bc_to":null,"bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"Rs 20 per share","event_id":"INE159A01:2020-07-17:dividend:1","ex":"2020-07-17","ex_move":{"move":-1.87,"on":["2020-07-17",1519.2],"pre":["2020-07-16",1548.1]},"exchanges":["BSE","MSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc"},"fields":{"div_amount":20.0,"payout_cr":338.81},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":"2020-07-13","nd_to":"2020-07-17","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2020-06-17","last_seen":"2020-07-17","purpose":"DIV-RS 20 SPLDIV-RS 20","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2020-06-17","last_seen":"2020-07-17","purpose":"DIV-RS 20 SPLDIV-RS 20","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Dividend - Rs 20 And Special Dividend - Rs 20 Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Special Dividend - Rs. - 20.0000","scrip":"500660","series":null,"src":"bse_dd","symbol":null},{"ex_from_record":false,"first_seen":"2026-10-05","last_seen":"2026-10-06","mse_symbol":"GLAXO","purpose":"AGM/Final Div Rs. 20/- & Special Div Rs. 20/-","scrip":null,"series":null,"src":"mse_ca","symbol":null}],"record":"2020-07-20","series":"BE","sources":["nse_pr_bc","nse_api","bse_dd","mse_ca"],"subtype":"special","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":null,"bc_to":null,"bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"Rs 30 per share","event_id":"INE159A01:2021-07-19:dividend:0","ex":"2021-07-19","ex_move":{"move":1.91,"on":["2021-07-19",1607.55],"pre":["2021-07-16",1577.35]},"exchanges":["BSE","MSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc"},"fields":{"div_amount":30.0,"payout_cr":508.22},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":"2021-07-13","nd_to":"2021-07-19","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2021-06-03","last_seen":"2021-07-19","purpose":"AGM/DIV - RS 30  PER SH","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2021-06-03","last_seen":"2021-07-19","purpose":"AGM/DIV - RS 30  PER SH","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Annual General Meeting/Dividend - Rs 30 Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Dividend - Rs. - 30.0000","scrip":"500660","series":null,"src":"bse_dd","symbol":null},{"ex_from_record":false,"first_seen":"2026-10-05","last_seen":"2026-10-06","mse_symbol":"GLAXO","purpose":"Final Dividend Rs. 30/- per share","scrip":null,"series":null,"src":"mse_ca","symbol":null}],"record":"2021-07-20","series":"BE","sources":["nse_pr_bc","nse_api","bse_dd","mse_ca"],"subtype":"final","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":null,"bc_to":null,"bse_scrip":null,"class":"equity","confidence":1.0,"detail":"","event_id":"INE159A01:2021-07-19:meeting:0","ex":"2021-07-19","exchanges":["NSE"],"field_provenance":{},"fields":{},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":null,"nd_to":null,"payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2021-06-03","last_seen":"2021-07-19","purpose":"AGM/DIV - RS 30  PER SH","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2021-06-03","last_seen":"2021-07-19","purpose":"AGM/DIV - RS 30  PER SH","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Annual General Meeting/Dividend - Rs 30 Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"}],"record":"2021-07-20","series":"BE","sources":["nse_pr_bc","nse_api"],"subtype":"agm","symbol":"GLAXO","type":"meeting"},{"announce":null,"bc_from":null,"bc_to":null,"bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"Rs 30 per share","event_id":"INE159A01:2022-07-07:dividend:0","ex":"2022-07-07","ex_move":{"move":-2.78,"on":["2022-07-07",1504.45],"pre":["2022-07-06",1547.4]},"exchanges":["BSE","MSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc"},"fields":{"div_amount":30.0,"payout_cr":508.22},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":"2022-07-01","nd_to":"2022-07-07","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2022-06-14","last_seen":"2022-07-07","purpose":"DIV-RS30/SPLDIV-RS60","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2022-06-14","last_seen":"2022-07-07","purpose":"DIV-RS30/SPLDIV-RS60","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Dividend - Rs 30  Per Share/Special Dividend- Rs 60 Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Dividend - Rs. - 30.0000","scrip":"500660","series":null,"src":"bse_dd","symbol":null},{"ex_from_record":false,"first_seen":"2026-10-05","last_seen":"2026-10-06","mse_symbol":"GLAXO","purpose":"Final Dividend Rs.30 & Special Dividend Rs. 60/-","scrip":null,"series":null,"src":"mse_ca","symbol":null}],"record":"2022-07-08","series":"BE","sources":["nse_pr_bc","nse_api","bse_dd","mse_ca"],"subtype":"final","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":null,"bc_to":null,"bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"Rs 60 per share","event_id":"INE159A01:2022-07-07:dividend:1","ex":"2022-07-07","ex_move":{"move":-2.78,"on":["2022-07-07",1504.45],"pre":["2022-07-06",1547.4]},"exchanges":["BSE","MSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc"},"fields":{"div_amount":60.0,"payout_cr":1016.44},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":"2022-07-01","nd_to":"2022-07-07","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2022-06-14","last_seen":"2022-07-07","purpose":"DIV-RS30/SPLDIV-RS60","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2022-06-14","last_seen":"2022-07-07","purpose":"DIV-RS30/SPLDIV-RS60","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Dividend - Rs 30  Per Share/Special Dividend- Rs 60 Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Special Dividend - Rs. - 60.0000","scrip":"500660","series":null,"src":"bse_dd","symbol":null},{"ex_from_record":false,"first_seen":"2026-10-05","last_seen":"2026-10-06","mse_symbol":"GLAXO","purpose":"Final Dividend Rs.30 & Special Dividend Rs. 60/-","scrip":null,"series":null,"src":"mse_ca","symbol":null}],"record":"2022-07-08","series":"BE","sources":["nse_pr_bc","nse_api","bse_dd","mse_ca"],"subtype":"special","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":null,"bc_to":null,"bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"Rs 32 per share","event_id":"INE159A01:2023-06-30:dividend:0","ex":"2023-06-30","ex_move":{"move":-0.93,"on":["2023-06-30",1425.1],"pre":["2023-06-28",1438.55]},"exchanges":["BSE","MSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc"},"fields":{"div_amount":32.0,"payout_cr":542.1},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":"2023-06-23","nd_to":"2023-06-30","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2023-06-23","last_seen":"2023-06-28","purpose":"DIV - RS 32 PER SH","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2023-06-23","last_seen":"2023-06-28","purpose":"DIV - RS 32 PER SH","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Dividend - Rs 32  Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Final Dividend - Rs. - 32.0000","scrip":"500660","series":null,"src":"bse_dd","symbol":null},{"ex_from_record":false,"first_seen":"2026-10-05","last_seen":"2026-10-06","mse_symbol":"GLAXO","purpose":"Final Dividend Rs 32/- per share","scrip":null,"series":null,"src":"mse_ca","symbol":null}],"record":"2023-06-30","series":"BE","sources":["nse_pr_bc","nse_api","bse_dd","mse_ca"],"subtype":"final","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":null,"bc_to":null,"bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"Rs 32 per share","event_id":"INE159A01:2024-05-31:dividend:0","ex":"2024-05-31","ex_move":{"move":0.96,"on":["2024-05-31",2619.3],"pre":["2024-05-30",2594.3]},"exchanges":["BSE","MSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc"},"fields":{"div_amount":32.0,"payout_cr":542.1},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":"2024-05-31","nd_to":"2024-05-31","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2024-05-24","last_seen":"2024-05-31","purpose":"DIV - RS 32 PER SH","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2024-05-24","last_seen":"2024-05-31","purpose":"DIV - RS 32 PER SH","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Dividend - Rs 32 Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Final Dividend - Rs. - 32.0000","scrip":"500660","series":null,"src":"bse_dd","symbol":null},{"ex_from_record":false,"first_seen":"2026-10-05","last_seen":"2026-10-06","mse_symbol":"GLAXO","purpose":"Final Dividend - Rs. 32.00/- per share","scrip":null,"series":null,"src":"mse_ca","symbol":null}],"record":"2024-05-31","series":"BE","sources":["nse_pr_bc","nse_api","bse_dd","mse_ca"],"subtype":"final","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":null,"bc_to":null,"bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"Rs 12 per share","event_id":"INE159A01:2024-11-07:dividend:0","ex":"2024-11-07","ex_move":{"move":-0.69,"on":["2024-11-07",2611.5],"pre":["2024-11-06",2629.6]},"exchanges":["BSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc"},"fields":{"div_amount":12.0,"payout_cr":203.29},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":"2024-11-07","nd_to":"2024-11-07","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2024-10-31","last_seen":"2024-11-07","purpose":"INTDIV - RS 12 PER SH","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2024-10-31","last_seen":"2024-11-07","purpose":"INTDIV - RS 12 PER SH","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Interim Dividend - Rs 12 Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Interim Dividend - Rs. - 12.0000","scrip":"500660","series":null,"src":"bse_dd","symbol":null}],"record":"2024-11-07","series":"BE","sources":["nse_pr_bc","nse_api","bse_dd"],"subtype":"interim","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":null,"bc_to":null,"bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"Rs 42 per share","event_id":"INE159A01:2025-05-30:dividend:0","ex":"2025-05-30","ex_move":{"move":1.08,"on":["2025-05-30",3298.6],"pre":["2025-05-29",3263.4]},"exchanges":["BSE","MSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc"},"fields":{"div_amount":42.0,"payout_cr":711.51},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":"2025-05-30","nd_to":"2025-05-30","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2025-05-28","last_seen":"2025-05-30","purpose":"DIV - RS 42 PER SH","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2025-05-28","last_seen":"2025-05-30","purpose":"DIV - RS 42 PER SH","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":null,"last_seen":null,"purpose":"Dividend - Rs 42 Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Final Dividend - Rs. - 42.0000","scrip":"500660","series":null,"src":"bse_dd","symbol":null},{"ex_from_record":false,"first_seen":"2026-10-05","last_seen":"2026-10-06","mse_symbol":"GLAXO","purpose":"Final Dividend - Rs.42/- per equity share","scrip":null,"series":null,"src":"mse_ca","symbol":null}],"record":"2025-05-30","series":"BE","sources":["nse_pr_bc","nse_api","bse_dd","mse_ca"],"subtype":"final","symbol":"GLAXO","type":"dividend"},{"announce":null,"bc_from":null,"bc_to":null,"bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"Rs 57 per share","event_id":"INE159A01:2026-05-29:dividend:0","ex":"2026-05-29","ex_move":{"move":-3.75,"on":["2026-05-29",2210.2],"pre":["2026-05-27",2296.2]},"exchanges":["BSE","MSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc","div_pct_fv":"bse_corpact","fv_used":"bse_corpact"},"fields":{"div_amount":57.0,"div_pct_fv":570.0,"fv_used":10.0,"payout_cr":965.61},"flags":["fv_from_counterpart"],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":"2026-05-29","nd_to":"2026-05-29","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2026-05-20","last_seen":"2026-05-29","purpose":"DIV - RS 57 PER SH","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-05-20","last_seen":"2026-05-29","purpose":"DIV - RS 57 PER SH","scrip":null,"series":"BL","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-05-20","last_seen":"2026-05-29","purpose":"DIV - RS 57 PER SH","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-05-20","last_seen":"2026-05-29","purpose":"DIV - RS 57 PER SH","scrip":null,"series":"IQ","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-05-20","last_seen":"2026-05-29","purpose":"DIV - RS 57 PER SH","scrip":null,"series":"T0","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-05-20","last_seen":"2026-05-29","purpose":"DIV - RS 57 PER SH","scrip":null,"series":"TL","src":"nse_pr_bc","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-09-15","last_seen":"2026-11-12","purpose":"Dividend - Rs 57 Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-09-26","last_seen":"2026-09-26","purpose":"Final Dividend - Rs. - 57.0000","scrip":"500660","series":null,"src":"bse_dd","symbol":null},{"ex_from_record":true,"first_seen":"2026-09-11","last_seen":"2026-11-12","purpose":"DP-570%","scrip":"100660","series":null,"src":"bse_corpact","symbol":null},{"ex_from_record":false,"first_seen":"2026-10-05","last_seen":"2026-10-06","mse_symbol":"GLAXO","purpose":"Final Dividend - Rs. 57/- per share","scrip":null,"series":null,"src":"mse_ca","symbol":null}],"record":"2026-05-29","series":"BE","sources":["nse_pr_bc","nse_api","bse_dd","bse_corpact","mse_ca"],"subtype":"final","symbol":"GLAXO","type":"dividend"},{"announce":"2026-10-13","bc_from":null,"bc_to":null,"bse_scrip":"500660","class":"equity","confidence":1.0,"detail":"Financial results for the period ended Sep 2026","event_id":"INE159A01:2026-11-03:meeting:0","ex":"2026-11-03","exchanges":["BSE","NSE"],"field_provenance":{"agenda":"nse_bm","attachment":"nse_bm","period":"nse_bm"},"fields":{"agenda":["results"],"attachment":"https://nsearchives.nseindia.com/corporate/xbrl/PRIOR_INTIMATION_1095_WebXMLFile_20261013_160446828.xml","period":"2026-09"},"flags":[],"group":"equity","instrument_id":"INE159A01016","isin_after":null,"isin_at_event":"INE159A01016","issuer_id":"INE159A","lineage":"INE159A01","name":"GlaxoSmithKline Pharmaceuticals Limited","nd_from":null,"nd_to":null,"payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2026-10-13","last_seen":"2026-11-12","purpose":"BOARD MEETING: Board Meeting Intimation | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 03-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .","scrip":null,"series":"EQ","src":"nse_bm","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-10-13","last_seen":"2026-11-12","purpose":"BOARD MEETING: Financial Results | To consider and approve the financial results for the period ended September 30, 2026","scrip":null,"series":"EQ","src":"nse_bm","symbol":"GLAXO"},{"ex_from_record":false,"first_seen":"2026-10-14","last_seen":"2026-11-12","purpose":"BOARD MEETING: Quarterly Results","scrip":"500660","series":null,"src":"bse_bm","symbol":null}],"record":null,"series":"EQ","sources":["nse_bm","bse_bm"],"subtype":"board","symbol":"GLAXO","type":"meeting"}],"instruments":[{"bse":["100660"],"class":"equity","coupon_pct":null,"coupon_src":null,"frequency":null,"isin":"INE159A01016","last_event":"2026-11-03","maturity":null,"n_events":35,"name":"GlaxoSmithKline Pharmaceuticals Limited","next_event":null,"nse":["GLAXO"],"status":"listed","symbol":"GLAXO","ticker":"GLAXO"}],"issuer":{"bse_scrips":["500660","100660"],"bse_tickers":["GLAXO"],"classes":{"equity":1},"delisted_on":null,"equity_isins":["INE159A01016"],"file":"INE159A","first_year":"2001","industry":"Pharmaceuticals & Biotechnology","issuer_id":"INE159A","last_seen":"2026-11-12","last_year":"2026","mse_listed":false,"mse_symbols":["GLAXO"],"n_events":35,"n_instruments":1,"name":"GlaxoSmithKline Pharmaceuticals Limited","names":["GlaxoSmithKline Pharmaceuticals Limited"],"next_ex":null,"nse_symbols":["GLAXO"],"px":true,"sector":"Healthcare","slug":"GLAXO","status":"listed"}}